Aleta’s mission is to create cell therapeutics that provide robust and durable clinical benefit for patients suffering from advanced hematologic cancers and refractory solid tumors. Aleta’s CAR-T Engager technology incorporates potent multi-antigen targeting, optimal T cell fitness, and persistence to aggressively attack cancers. We use this technology to build programs that solve specific clinical issues, including cell therapy relapses due to antigen loss and the challenge of overcoming solid tumor heterogeneity. Our lead development program has won landmark clinical support from Cancer Research UK and will enter Phase1/2 trials in 2022.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 27 Strathmore Rd, Natick,ma 01760,united States
- Phone
- (508) 282-6370
- Industry
- Biotechnology
- Website
- http://aletabio.com
- HQ
- Natick, MA
Aleta Biotherapeutics Questions
Aleta Biotherapeutics's helpline number is (508) 282-6370
Aleta Biotherapeutics's website is http://aletabio.com
Aleta Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/aletabio
Aleta Biotherapeutics has
6 employees.
View email and phone details for 6
employees at Aleta Biotherapeutics.
Aleta Biotherapeutics's industry is
Biotechnology
Aleta Biotherapeutics's top competitors are
Minerva Biotechnologies,
Orna Therapeutics,
Nura Bio,
Nickl Therapeutics,
Pillar Biosciences Incorporated,
Go Therapeutics,
Arcellx,
Poseida Therapeutics, Inc.,
Immunobrain,
Affyimmune Therapeutics.
Aleta Biotherapeutics's categories are Biotechnology
Aleta Biotherapeutics's founding year is 2006
